Virginie Thepenier

Title: Virginie Thepenier: Innovator in Immunotherapy

Introduction

Virginie Thepenier is a prominent inventor based in Sainte Pazanne, France. She has made significant contributions to the field of immunotherapy, particularly in the development of innovative treatments for cancer and autoimmune disorders. With a total of seven patents to her name, her work is paving the way for new therapeutic approaches.

Latest Patents

Among her latest patents is the "Humanized anti-human-PD-1 antibody and methods of using them for cancer treatment." This invention describes humanized anti-PD-1 antibodies, nucleic acids encoding such antibodies, and their uses in enhancing immune responses by activating T cells to treat diseases like cancer and infectious diseases. Another notable patent is focused on the "Uses of anti-SIRPg antibodies," which provides new applications for these antibodies in the treatment and prevention of autoimmune disorders or diseases.

Career Highlights

Virginie Thepenier is currently associated with Ose Immunotherapeutics, where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving patient outcomes through innovative therapeutic solutions.

Collaborations

She collaborates with notable colleagues, including Nicolas Poirier and Caroline Mary, to further enhance the impact of her research in the field of immunotherapy.

Conclusion

Virginie Thepenier's contributions to immunotherapy exemplify the potential of innovative treatments in addressing complex health challenges. Her patents and ongoing research are vital to the future of cancer treatment and autoimmune disease management.